United States · Who invested in Therion Biologics Corporation?
Therion Biologics Corporation's investors include SR One, CDP Capital Technology Ventures, Hambrecht & Quist, Hans-Werner Hector and New York Life Bioventure Partners.
United States · Venture startup
Who invested in Therion Biologics Corporation
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$39Mraised across 1 round since 2003, from 1 source
- Latest round
- Venture, $39MSept 2003
- Investors
- 5
The rounds
- Sept 2003Venture$39M
SR One- CDP Capital Technology Ventures
- Hambrecht & Quist
- Hans-Werner Hector
- New York Life Bioventure Partners
From a historical funding record
Everyone who backed them
CDP Capital Technology VenturesVC firm1round
Hambrecht & QuistInvestment bank1round
Hans-Werner Hectorno record of our own yet1round
New York Life Bioventure Partnersno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Therion Biologics Corporation
How much has Therion Biologics Corporation raised?
Therion Biologics Corporation has raised $39M across 1 round since 2003.
When did Therion Biologics Corporation last raise?
Therion Biologics Corporation's most recent round was a Venture of $39M in Sept 2003.
What was Therion Biologics Corporation's biggest round?
Its most recent round, $39M in Sept 2003, is also its largest on record.
Who backed Therion Biologics Corporation first?
Therion Biologics Corporation's first round on record, in Sept 2003, was backed by SR One, CDP Capital Technology Ventures and Hambrecht & Quist and 2 others.
What stage is Therion Biologics Corporation at?
Therion Biologics Corporation's latest named round is a Venture, in Sept 2003.
Where is Therion Biologics Corporation based?
Therion Biologics Corporation is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.